Latest Regulatory News

333D Limited has had its trading suspension lifted following a capital raise announcement and response to an ASX price query, signaling renewed market activity.

333D Limited has confirmed a $1 million placement to fund significant upgrades to its digital asset management platform, explaining a recent sharp rise in its share price and trading volume.

Falcon Metals has reported impressive high-grade gold intercepts at its Blue Moon prospect, confirming continuation of historic reef lines and securing a second drill rig to accelerate exploration.

Assetora Limited has locked in a $3 million private placement from CloudTech Group, aiming to strengthen its balance sheet and fuel expansion plans. The deal unfolds in two tranches, with key conditions tied to audited reports and ASX reinstatement.

Regis Healthcare acknowledges the Australian Government’s recent announcement to increase aged care funding through higher AN-ACC prices and hotelling supplements, aimed at supporting wage rises for care workers. The company is currently assessing the financial implications of these changes.

Aguia Resources has updated its economic study for the Tres Estrades Rock Phosphate Project, reflecting a significant uplift in phosphate pricing and expanded production capacity that together enhance the project's financial outlook.

Peninsula Energy has successfully produced its first batch of dried yellowcake uranium at the Lance Project in Wyoming, marking a major step toward becoming a fully independent uranium producer in the US.

Paladin Energy Ltd has launched a significant A$300 million underwritten equity raising to advance its Patterson Lake South uranium project and support the ramp-up of its Langer Heinrich Mine, reinforcing its position in the global uranium market.

Rapid Critical Metals Limited has requested an immediate suspension of its ASX securities to finalize a significant capital raising, with trading expected to resume upon announcement or by 17 September.

TMK Energy Limited’s trading suspension on the ASX has been lifted as the company lodges its Half Yearly Report, reopening its shares to market activity from 16 September 2025.

Orthocell’s nerve repair device Remplir is being adopted in Australia for nerve-sparing prostate cancer surgeries, aiming to reduce erectile dysfunction and urinary incontinence post-operation. This development could significantly expand Remplir’s market reach globally.

Thor Energy has agreed to sell its 75% stake in the FRAM Joint Venture to Tivan Limited for A$8.75 million, significantly strengthening its balance sheet and accelerating its focus on natural hydrogen and helium exploration in South Australia.